Literature DB >> 20428971

Role of human papillomavirus in the development of urothelial carcinoma.

Dilek Yavuzer1, Nimet Karadayi, Taflan Salepci, Huseyin Baloglu, Ahmet Bilici, Dilek Sakirahmet.   

Abstract

It has been estimated that almost 10% of the worldwide cancer burden is linked to human papillomavirus (HPV) infection. Although the association between HPV and bladder carcinoma has been extensively investigated, data on the role of HPV in bladder carcinogenesis are controversial. The aim of the study was to assess the possible role of human papillomavirus in the development of urothelial bladder carcinomas. Formalin-fixed and paraffin-embedded archival tissue samples were used for DNA extraction. Seventy urothelial bladder carcinoma tissues were screened by nested-polymerase chain reaction (PCR) for HPV DNA with a control group of total 18 cervical tissues with invasive cervical carcinoma and cervical intraepithelial neoplasia III (CIN III). In the study group, we did not find HPV DNA positivity in any of the urothelial carcinomas. In the control group, 15 out of 18 (83.3%) samples were positive for the HPV DNA. These results indicated that there was no association between HPV infection and urothelial carcinomas.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20428971     DOI: 10.1007/s12032-010-9540-1

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  30 in total

1.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

2.  Lack of evidence for a role of human papillomaviruses in transitional cell carcinoma of the bladder.

Authors:  O Aynaud; P Tranbaloc; G Orth
Journal:  J Urol       Date:  1998-01       Impact factor: 7.450

3.  Investigation of human papillomavirus in transitional cell carcinomas of the urinary bladder in South Africa.

Authors:  M Sur; K Cooper; U Allard
Journal:  Pathology       Date:  2001-02       Impact factor: 5.306

Review 4.  The history of tumor virology.

Authors:  Ronald T Javier; Janet S Butel
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

5.  High-risk human papillomavirus infections and overexpression of p53 protein as prognostic indicators in transitional cell carcinoma of the urinary bladder.

Authors:  M Furihata; K Inoue; Y Ohtsuki; H Hashimoto; N Terao; Y Fujita
Journal:  Cancer Res       Date:  1993-10-15       Impact factor: 12.701

Review 6.  Unsuccessful effort to detect human papillomavirus DNA in urinary bladder cancers by the polymerase chain reaction and in situ hybridization.

Authors:  T Sano; S Sakurai; T Fukuda; T Nakajima
Journal:  Pathol Int       Date:  1995-07       Impact factor: 2.534

Review 7.  Transitional cell carcinoma of the bladder: evaluation of the role of human papillomaviruses.

Authors:  J C Noel; L Thiry; A Verhest; N Deschepper; M O Peny; A A Sattar; C C Schulman; J Haot
Journal:  Urology       Date:  1994-11       Impact factor: 2.649

Review 8.  Molecular mechanisms of human papillomavirus-induced carcinogenesis.

Authors:  Michaël Lehoux; Claudia M D'Abramo; Jacques Archambault
Journal:  Public Health Genomics       Date:  2009-08-11       Impact factor: 2.000

9.  Detection and typing of human papillomaviruses combining different methods: polymerase chain reaction, restriction fragment length polymorphism, line probe assay and sequencing.

Authors:  Nina Milutin Gasperov; Ivan Sabol; Mihaela Matovina; Sime Spaventi; Magdalena Grce
Journal:  Pathol Oncol Res       Date:  2008-08-28       Impact factor: 3.201

10.  Molecular Signature of HPV-Induced Carcinogenesis: pRb, p53 and Gene Expression Profiling.

Authors:  Agueda Buitrago-Pérez; Guillermo Garaulet; Ana Vázquez-Carballo; Jesús M Paramio; Ramón García-Escudero
Journal:  Curr Genomics       Date:  2009-03       Impact factor: 2.236

View more
  9 in total

1.  Low prevalence of HPV detection and genotyping in non-muscle invasive bladder cancer using single-step PCR followed by reverse line blot.

Authors:  Renate Pichler; Wegene Borena; Georg Schäfer; Claudia Manzl; Zoran Culig; Sebastian List; Sabrina Neururer; Dorothee Von Laer; Isabel Heidegger; Helmut Klocker; Wolfgang Horninger; Hannes Steiner; Andrea Brunner
Journal:  World J Urol       Date:  2015-03-19       Impact factor: 4.226

2.  Association of human papilloma virus (HPV) infection with oncological outcomes in urothelial bladder cancer.

Authors:  Solmaz Ohadian Moghadam; Kamyar Mansori; Mohammad Reza Nowroozi; Davoud Afshar; Behzad Abbasi; Ali Nowroozi
Journal:  Infect Agent Cancer       Date:  2020-08-28       Impact factor: 2.965

3.  Urinary human polyomavirus and papillomavirus infection and bladder cancer risk.

Authors:  J Polesel; T Gheit; R Talamini; N Shahzad; O Lenardon; B Sylla; C La Vecchia; D Serraino; M Tommasino; S Franceschi
Journal:  Br J Cancer       Date:  2011-11-24       Impact factor: 7.640

4.  Meta-analysis of studies analyzing the role of human papillomavirus in the development of bladder carcinoma.

Authors:  Antonio Jimenez-Pacheco; Manuela Exposito-Ruiz; Miguel A Arrabal-Polo; Alfonso J Lopez-Luque
Journal:  Korean J Urol       Date:  2012-04-18

5.  Human papilloma virus is not detectable in samples of urothelial bladder cancer in a central European population: a prospective translational study.

Authors:  Sebastian C Schmid; Leonore Thümer; Tibor Schuster; Thomas Horn; Florian Kurtz; Julia Slotta-Huspenina; Judith Seebach; Michael Straub; Tobias Maurer; Michael Autenrieth; Hubert Kübler; Margitta Retz; Ulrike Protzer; Jürgen E Gschwend; Dieter Hoffmann
Journal:  Infect Agent Cancer       Date:  2015-09-21       Impact factor: 2.965

Review 6.  Prevalence of Human Papilloma Virus Infection in Bladder Cancer: A Systematic Review.

Authors:  Narcisa Muresu; Biagio Di Lorenzo; Laura Saderi; Illari Sechi; Arcadia Del Rio; Andrea Piana; Giovanni Sotgiu
Journal:  Diagnostics (Basel)       Date:  2022-07-20

7.  HRAS mutations are frequent in inverted urothelial neoplasms.

Authors:  Andrew S McDaniel; Yali Zhai; Kathleen R Cho; Saravana M Dhanasekaran; Jeffrey S Montgomery; Ganesh Palapattu; Javed Siddiqui; Todd Morgan; Ajjai Alva; Alon Weizer; Cheryl T Lee; Arul M Chinnaiyan; Michael J Quist; Catherine S Grasso; Scott A Tomlins; Rohit Mehra
Journal:  Hum Pathol       Date:  2014-06-18       Impact factor: 3.466

8.  Overexpression of p16(INK4a) in urothelial carcinoma in situ is a marker for MAPK-mediated epithelial-mesenchymal transition but is not related to human papillomavirus infection.

Authors:  Julie Steinestel; Marcus V Cronauer; Johannes Müller; Andreas Al Ghazal; Peter Skowronek; Annette Arndt; Klaus Kraft; Mark Schrader; Andres J Schrader; Konrad Steinestel
Journal:  PLoS One       Date:  2013-05-28       Impact factor: 3.240

9.  Bladder cancer and human papillomavirus association: a systematic review and meta-analysis.

Authors:  Alireza Khatami; Zahra Salavatiha; Mohammad Hossein Razizadeh
Journal:  Infect Agent Cancer       Date:  2022-01-21       Impact factor: 2.965

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.